Saturday, December 31, 2005

THE GOOD, THE BAD, THE UGLY

THE GOOD, THE BAD, THE UGLY

It’s that time again that I have to review the year. Despite the ups and downs, I am rather satisfied with this year's performance, more importantly, I have learnt a lot from this year’s experience. After all, this review is a rear-window view and what I have learnt will benefit me in the future. Without further due, here it is.

THE GOOD

1. Learning Experience. I have to put “LEARNING� on the top of my good list, intangible notwithstanding. This is the year that I truly feel that I have learnt a lot from my experience, both bad and good ones. Let’s see if I could summarize them here. I had read more extensively this year than ever. I had listened to everyone, analysts (both buying and selling sides, portfolio managers, economists, Cramer). I started to develop my own system earlier this year and it started to work for me. I will reflect some of the lessens learned throughout this review.

2. Exceeding Target. I managed to meaningfully exceed my targets for fiscal year 2005. We saved more than planed, even though we had our share of unexpected this year (17.7% vs. 10%), and we generated a much greater return than expected (17% vs. 10%). On the managed portfolio, I managed to generate 11.5%, compared to our modest 7.5% target. The overall return of 35% this year will be hard to beat going forward. The total portfolio of $410K exceed our target of $375 by $35K, or 9.3%. The wealth increased by $105K this year. Given our income level and cash flow circumstances, this is rather remarkable. It is even more remarkable given that I have to continue to get rid of my past losers and mistakes. This is an excellent performance by any standard.

3. Good Picks. A lot of terrific picks this year with excellent returns, particularly in the small caps, most after good independent research work. There are so many, and I do not intent to list them all here.

4. Homework. Started to develop my own system. Earlier this year, I started to look for “exceeding expectation stocks, with reasonable valuation� and it worked out quiet well, particularly for small caps. Later, I started to develop a simple system where the growth rate, ROE, and multiples are weighted, scored, and ranked. I have been picking those with relatively high score. I also started to screen sectors by using the score system and it had indeed generated some attractive picks. While the system needs refining, I believe it is a decent system. First and foremost, it will likely avoid bad ones, i.e. those without earnings, have low ROE, or valuation is too high.

5. Showed more flexibility. There were only two major buying opportunities, one in April-May and one in late October. I managed to add more positions in both lows, despite considerable emotional pains and suffering. “When in pain, buy more� becomes this year’s motto. I am still learning how to sell though, as I believe I am still very much amateurish in taking profits.

6. Cleaned up a lot of “deadwood�. I continued to clean “deadwood� of previous mistakes. While the portfolio still have losses, I believe I have more or less gotten rid of all true deadwood and moved forward.

7. Speculated less. After housing cleaning earlier this year, I have made a great deal of efforts to speculate less, or to limit the speculate position or dollar amount to the minimum. While I still have some speculative positions, their positions are relatively small, and their natures well aware.

8. Research. I had done a lot of research work this year. I had gone through a lot of quarter reports, 10Q / 10K. I had gone to a lot of conference calls and I had read a lot of research reports. Most fund managers are not Buffet, but they do possess more information than individual investors. I believe I have narrowed that gap a bit this year.

9. Record Keeping. I had a reasonable plan with achievable target, well in place. I kept every trade made. I reasoned with myself before I executed. The record keeping is important as it really helps me to focus on the forest, instead individual trees. It also helps me avoiding mistakes.

10. Open Mind. I kept an open mind this year, and looked beyond my traditional resource, finance and technology areas. Income trusts had generated a decent return for me this year and I would have missed it had I not kept an open mind this year (I had indeed missed the biggest investment opportunity ever).

11. Limited losses. While I put this in the “Good� category, I have to give me only a “pass� grade as my failure to sell a few positions had resulted in fairly significant losses. In fact, had I been able to limited their losses by half, my return would have been in lower 20s, instead of lower 10s. Having said that, I was very conscious this year and if the fundamentals deteriorated, I generally sold my position without too much hesitation, most of which turned out to be the correct decisions.

12. Informed decisions. I used to take positions before the earning reports, HOPING good results and a spectacular pop. The key word it “HOPING� because I had no clue what the results would be, so were all others. This is exactly what speculating means, even for quality company. One thing I truly learnt this year is to take positions after the earning results, i.e. making informed decisions. And the results have been surprisingly good. Not only was I able to pick a few good stocks, I was also able to dump a few losers as quickly as possible. More importantly, making informed decisions results in more rational thinking, and avoids panic. I shall never take on any positions without first reading their reports.

13. Buying panic. I made conscious effort this year to buy “PANIC� this year. Buying panic only works if you are aware of, and believe in good stocks (which require a lot of on-going research works), when panic selling occurs. I was able to pick up ADS, WCG, ELOS, NSTC, COM.TO at panic prices (not without emotional pain and sufferings, though).

14. Trust Income. I was converted into a believer of Income Trust earlier this year and started establishing positions. While I had come to the party rather late, and despite the ups and downs, the trusts had generated decent return for me. I continue to like its tax efficiency and profit-taking discipline. For me, a trust is a tax reduction for trust holders. If you do not own it, you miss the tax cut. Secondly, trusts take profit every month, a much more disciplined product for me.

15. A few good books. Other than financial statements, 10Q/10Ks, I actually read a few good books this year, and I intend to read a few more in the New Year.

THE BAD

1. Selling too earlier. I continued to have major problems of selling way too earlier, and I believe this is the area that I need to improve the most. My portfolio is littered with these stocks I did not know where to start. For example, I picked WLE at 2.85 and sold it at about 5.0 for a 75% return, pretty impressive, ah? NOT! It went up to 17.5 by the end of the year, that would be a 600% return, and I missed 525%! This pick alone would have doubled my entire year’s return had I kept it. Even I kept half, my return would have been much greater. I picked IIC at 33.5 and sold it at 34, basically lost patience after two quarters. It went up to 55, almost as soon as I sold it! To rub it in, I purchased two securities subsequently, using the cash proceeds, both of which were losers. Ensign, I picked up at 22.65 and sold it at 26.9 for a 17% return, it went up to 50 by the year end, 120.75% return! TEK, picked up at 36, and sold at 45, again, a decent return of 25%, it went on to $60, a 65% return. There were also quite a few positions where I panicked, resulting in losses, and they went on to generate significant returns. On the other side of the ledger, positions I had held for longer time, generated significant returns for me. Lessens leant: let your winners run.

2. Selling too late. On the other hand, a couple of positions there I sold too late. One obvious one is Jean Coutu. I read the earning release, I listened conference call. I knew the results were not good. The stock was held and I could get rid my entire position at 18.5. I hesitated, just for a few seconds, and it was a free fall, all the way to 12. My loss exploded from 2% to 37%. But the honor had to belong to CJC where after the disappointed testing results, I did not sold at 5.0 level. It went down all the way to 0.62. A complete written off! Without CJC, my return for 2005 would have been spectacular. On macro level, there were two major peaks this year, one in March and one during August-September, and I obviously missed both. The March peak was particularly painful for me as my return fell off cliff, from 10%+, all the way to –5%. The end of the year appears to be a peak, at least for 2005, should I learn from experience and sell some here?

3. Trading too much. I did almost 200 trades this year, a lot of them in panic situations. That is way too much for a small investor like me, and that is a lot of commission for my broker. My New Year resolution is to cut that number at least by half.

4. Speculating too much. Although it sounds contradicting to previous passage, I still speculated too much, particularly in early part of the year. I gradually reduced my speculative positions throughout the year to minimum. On the positive side, at least I am fully aware of the nature of these positions and I have made an effort to control their positions as little as possible.

5. Value Trap. One of the major failure this year is the picks of “value traps�. I always have the tendency to look for cheap stocks, which tends to lead to picking up of value traps. I have plenty this year, including but not limited to ABT, BXS, WYN, ORCL, MSFT, PJC.TO, none of which have provided me with decent returns. Another resolution of 2006 is to make a conscious effort to buy “the best breed�, instead of the cheapest stocks.

6. Bad advice from analysts. I still listened too much of what analysts said, not that they were all bad though, but a lot were.

THE UGLY

Drum roll please: The honor goes to CJC, a total written off for this year, although to be fair, it is one piece of the deadwood, as I bought most of them in 2003 and 2004. This was a typical case. I listened the conference all and I pretty much knew the results were not good and the market wouldn’t like it. But when the market tumbled to $5.0 level, I hesitated and did nothing. After which, the thinking went as: “ it had come down so much, how much could it go down further�? It could and it did, all the way to 0.62. The other aspect of this dog is that I knew it was speculative, nonetheless, my position was way to significant for a speculative stocks. I believe this shall not happen again going forward because I will limit it to no greater than 2% and I will sell it as soon as fundamentals deteriorate.

Other honorable mentioned included: DY.TO, SFCC, PFC.TO, TMY.TO.


CONCLUSION

Overall 2005 is not a bad year for me. I achieved all my modest targets and a little bit more in a pretty difficult market. I beat most of the US indexes, although under-performed TSE this year (which is pretty hard to beat, unless you were over-weight energy). More importantly, despite all those mistakes, I feel more confident in 2006 and beyond.

Thursday, December 22, 2005

LOSING MOMENTUM

CNTF

Sold the remaining position of CNTF at 13.30. I thought the market is (1) losing some steam; (2) overbought for the past few weeks; (3) while fourth quarter results are likely in bag, forward estimates are uncertain; (4) bullish sentiment is extremely strong. I would like to sell more into rally in the next few weeks and wait for the fourth quarter earnings.

MKX

Also sold MKX at 2.75. I just want to raise some cash given the over bought condition. This one has given me over 30% return over a very short period and I decide to take profit here. I can always buy it back later.

UTMD

I bought a small position of UTMD ($28.95) this afternoon. I really like this company due to the follows:

- Very strong, and consistent financial performance over the past 10 years;
- Decent growth for its revenues, operating income, earnings and free cash flow;
- Clean balance sheet with no debt;
- High ROE (over 20% over the past five years) and high ROC as capital requirement is very small;
- In the healthy care industry, non-cyclical and defensive;
- Leader in niche markets, large portion of its products are consumables and reoccurring;
- Insider buying and share repurchase program in place;
- I like the management team (from what I can read);

Moreover, I believe the stock is reasonably valued. I expect it to make about 1.90-1.95 for this year, which means the stock is only trading at about 15X of its 2005 EPS. More importantly, I believe its 2006 EPS will be at least 2.15-2.25 level in a static case. This is because the company has won a case against FDA (no less!) recently and I estimate that savings of legal expenses alone will amount to 0.25 per share for 2006. Furthermore, the closure of this case will likely result in meaningful increase of revenues, improving operating profit margin, and earnings for 2006. The company has a very strong earning leverage and small increase of revenues will result in large jump of its EPS. Even with the same multiple, it should be traded at 32.25-33.75 range next year. But I believe its multiple should expand given its decent growth perspective, potential acquisitions, and high levels of ROE and ROC. I expect its multiple to expand to 20X (more or less the same to its peers), which will result the stock price at 43-45 range in next 12 months. The company is relatively small (just above $100 million market cap) and there is no coverage. The only drawback is that it has only 4 million shares outstanding and is rather illiquid. But for a long term investment, it does not matter that much, dose it? Oh, did I mention that it pays a 0.6 dividend while you are waiting..


CPL

Calpine filed long expected Chapter 11 this morning. I am watching with interest in this restructuring, partly because I own some Calpine Power Income Trust here in Canada, partly I thought this is an interest Chapter 11 case which has a lot of characteristics outlined by Joel Greenbelt in his little yellow book. Basically CPL has sold assets, in an industry where demand continues to grow, and it is generating revenues, and cash flow. The problem is that it is highly leveraged, and hopefully Chapter 11 will take care of that. Secondly, there are a lot of debt out there (about 22 billions) and there will be a lot of shares over the Chapter 11 is complete, hence the second element, i.e. there might be a lot of bond holders, trade creditors, banks, and even vultures who may not want to hold new CPL shares, selling of which could create potential value. Third, as mentioned in (1), CPL has a lot of solid pieces of assets could be sold to generate cash, but more importantly, it could result in a smaller, but much more focused utility company, concentrating on the fasting growing markets such as Texas and California. This is going to be a very prolonged restructuring process and I shall pay attention to the last element, insiders incentives.

Thursday, December 15, 2005

AWFUL SOFTWARE COMPANY

ATRI / ORCL

ORCL announced last night and it was terrible (what else is new?). I sold my position in ORCL at the opening. No wonder the street is referring ORCL as “awful software company� because IT IS. With the cash, I bought some ATRI at 66.75 this morning. This one is a real sleep as it has less than 2 million shares outstanding. But I believe this one is really undervalued and it should be traded at 80 level. As long as the company continues to deliver its quarters, it does not even need any catalyst.

Wednesday, December 14, 2005

MORE HEALTH CARE PLEASE

CNU

I have been very quiet for the past few days. But I have been focus on research and have found a few stocks I like. Unfortunately, I am pretty much fully invested at this point. Good thing is all these stocks are fairly small and rather thinly traded, and probably will not jump up dramatically.

I did sold Q and RFC to raise some fund and put a bid for CNU this morning, a small cap (just over 100 million) in the health care industry. I could not find any weakness in this one. Top line growth: 10% over the past five years; Bottom line growth: 30%+ over the past three years; Operating income: over 100% 04/03; and 86% 05/04; Book value: over 100% over the past three years; Growth visability is good, driven by: increasing reimbursement rate; lower claim costs; increase patient volume, open more service centers, and selective acquisitions. Balance sheet is clean with more than $5.0 on book and a lot of working capital (mostly consisting of reimbursement receivables from government). Demographics: favorable with aging population and increasing demand for health care, particularly in the state of Florada. Strong return on equity (over 35%), strong return on assets, and return on capital. A lot of insiders purchases and a large share repurchase program (It has bought a lot of shares in the 2.5 range, showing a lot of confidence). It is in a rather defensive and non-cyclical industry and will not be as vulnerable to a potential economic slow down. Valuation is very reasonable, traded at only 13X of its 05 EPS. I conservatively expect it to make about 0.20 in fiscal year 2006, which will make its P/E at 11.5X. It is small, no analyst coverage. It scores a rather hgih 50 on my little proprietary model. If the company continues to deliver its quarters, I expect both solid earning growth, and multiple expansion. Even at 15X, it should be trading at about $3.0 within 12 months. The only drawback I can see is that it starts to pay taxes this year, which could impact on its EPS and it is rather thinly traded. This one is a sleeper though and it may require a lot of patience. (Filled at 2.29).

ATRI

Another small cap ($120 million market cap) that I could not find any weakness. Very strong growth, top-line, operating income and bottom-line (30%+); Steady improvement of margins; Strong balance sheet; Very strong cash flow; Paying a decent dividend; Strong management; Valuation is very reasonable, traded at 18X of its 2004 EPS, and 17X of its nine months 2005 EPS. Very reasonable indeed for a company growing at 30% over the past five years, in an industry where almost everyone is traded above 30x multiple. No analyst coverage. Again it is in a non-cyclical, defensive industry. The only problem is that it has less than 1.8 million shares outstanding and very thinly traded. (The other problem is that I have no money). I got to raise some fund and I need to buy this one.

Monday, December 05, 2005

THE HOUSE OF MORGAN

JPM

I bought some JPM (39) this morning. I am currently underweight financials, and it is about time to add some more here as Fed is about done to raise rate. Large US banks are much cheaper than their Canadian counterparitiesm, and with such strong C$, I might as well own US banks instead. JPM is currently traded at 1.2X of its book value. With the Fed out of way, it may expand to 1.5 or even 2.0 times in the next year, which would take it to 45-60 range, a rather decent return. Jamie Damon is in charge and we could see some productivity gain as well. Not to mention it has almost a 4% dividend yield. I have added quite a few small cap, growth stocks lately. The House of Morgan will provide a nice balance.

Sunday, December 04, 2005

SMALL CAPS

HOM / PRLS

I purchased a couple of small caps this morning. Both had a very strong quarter with significant growth, but are still traded at reasonable multiples (about 16X of 06EPS). Both have a market cap just over 100 million. If they can deliver Q4/05 and a decent outlook for 06, I would expect the multiple to expand to 20X. I first looked at PRLS when it was traded at 5.0 and never pulled the trigger. And now I have to pay 3.0 more. PRLS is rather volatile but HOM is a real sleeper.

Thursday, December 01, 2005

HAZARD OF INVESTING

SFCC

The hazard of investing. SFCC dropped another 20%+ today, (in the biggest rally of the year) for a couple of minor reasons (one downgrade, and some problems with its testing facility). I was totally paralyzed. The steep decline, in my view, is not warranted and the stock is extremely cheap. However, it is behaving as if there is more substance behind it. It certainly does not help that management remains deadly silent during this painful process. In hindsight, it appears that the company has poor governance and management appears rather investors-unfriendly, to say the least. What will be the worst scenario? Is this an Enron? All the issues surfaced up todate do not appear critical to me, nor do I believe its earning power will collapse as a result. As for the downgrading, it is from the same analyst who was promoting the same security at 40+. What should I do? Should I sell here and take my loss or should I let it play out. I wasn’t doing anything, I guess I have chosen the latter. It is so frustrating as I would have had a nice day. I do not like the feeling right here as I feel I am just about to reach the peak of a mountain, but ultimately fail.